Protein labeling is a method by which protein and its binding partners are identified using appropriate molecular labels for fast detection and purification. Proteins are labeled through the development of genetic fusion that adds distinctive properties to these proteins, this makes protein visualizations, manipulation, and trapping possible.
The global Growth in spending on research & development along with developing healthcare industry to drive the protein labeling market worth USD 4.14 billion by 2030, growing at a CAGR of 8.55 %
During cell growth, protein can be labeled by the incorporation of amino acids containing different isotopes, mass tags, and fluorophores. Increasing spending on the healthcare industry and an increase in research and development expenditure leading to a reduction in the protein labeling process complexity by the companies coupled with technological advancement in existing technologies are expected to accelerate the growth. Besides, the industry is witnessing many new launches of the products and rising adoption of bioengineering technologies is further contributing to the growth of the global market. However, limited applications of protein labeling and lack of skilled professionals are likely to hamper the growth of the global protein labeling market.
Cell-based assay application segment is expected to account for significant revenue share in the global market
The labeling market for protein application is used extensively for different purposes. Among all the applications, cell-based assays have the ability to provide more information about intracellular molecular targets. Hence, the cell-based assays segment is expected to hold the largest revenue share in the application segment over the forecast period.
North America is likely to dominate the protein labeling market
Geographically, the protein labeling market is classified into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. Among these, North America is expected to dominate the global market over the forecast period. The presence of a large number of key players and an increase in expenditure on genomic and proteomic research related to advances in bioengineering technologies are the major drivers contributing to the growth of the market in North America. In addition, factors such as an increase in the adoption of personalized medicines and genomic sequencing are likely to further contribute to the growth of the market.
Asia Pacific is expected to be the fastest-growing market over the forecast period owing to rising healthcare spending and investment in high omics research in a country like India & China fueling the significant growth in the market. Besides, innovations such as cancer proteomics, immunodynamics, and structural genomics further accelerate the growth of the market in this region.
Key Market Players
- F. Hoffmann-La Roche AG
- GE Healthcare Life Science
- Promega Corporation
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- PerkinElmer Inc.
- Kirkegaard & Perry Laboratories, Inc.
- Eurogentec S.A.
- LI-COR Inc.
- New England Biolabs, Inc.
Key Segment Of The protein labeling market
By Product, 2022-2030 (USD Million)
By Applications, 2022-2030 (USD Million)
• Cell-based Assays
• Fluorescence Microscopy
• Immunological Techniques
• Protein Microarray
• Mass Spectrometry
By Methods, 2022-2030 (USD Million)
• In-Vitro Labeling Methods
• In-Vivo Labeling Methods
Regional Overview, 2022-2030 (USD Million)
• Rest of Europe
• Rest of Asia Pacific
• Rest of South America
Middle East and South Africa